Physician profile
Jane Holt
NPI 1548467293
$1,591.21
in general payments reported to CMS, 2019-2025
19 companies · $316 in 2025
The $316 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $98.62 · 2021: $158 · 2022: $270 · 2023: $348 · 2024: $241 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $428.14 | 2019-2025 | Bexsero, Pediarix, Fluarix Quadrivalent |
| Corium, LLC | $394.37 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $92.02 | 2021-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Collegium Pharmaceutical, INC. | $86.13 | 2025 | Jornay Pm |
| Pfizer INC. | $80.14 | 2022-2024 | |
| Seqirus USA INC | $69.43 | 2022-2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $56.80 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $56.44 | 2019-2021 | |
| Sanofi Pasteur INC. | $54.30 | 2023-2025 | |
| Neurelis, INC. | $50.72 | 2023-2024 | Valtoco |
| Nestle Healthcare Nutrition INC. | $44.07 | 2023 | |
| Supernus Pharmaceuticals, INC. | $43.63 | 2021-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $36.86 | 2020-2021 | |
| Adlon Therapeutics L.P. | $25.14 | 2019-2020 | |
| Genentech USA, INC. | $17.19 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.24 | 2023 | Strensiq |
| Arbor Pharmaceuticals, INC. | $15.01 | 2019 | |
| Tris Pharma INC | $13.53 | 2022 | |
| Sobi, INC | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.